User profiles for Matthias Becker

Matthias D. Becker

- Verified email at stadtspital.ch - Cited by 7151

Matthias Becker

- Verified email at dzne.de - Cited by 1858

Matthias Becker

- Verified email at ibm.uni-hannover.de - Cited by 1273

[PDF][PDF] Severe COVID-19 is marked by a dysregulated myeloid cell compartment

…, MT Vinh, G Rieke, C Meisel, T Ulas, M Becker… - Cell, 2020 - cell.com
Coronavirus disease 2019 (COVID-19) is a mild to moderate respiratory tract infection, however,
a subset of patients progress to severe disease and respiratory failure. The mechanism …

Swarm learning for decentralized and confidential clinical machine learning

…, EJ Giamarellos-Bourboulis, M Kox, M Becker… - Nature, 2021 - nature.com
Fast and reliable detection of patients with severe and heterogeneous illnesses is a major
goal of precision medicine 1 , 2 . Patients with leukaemia can be identified using machine …

[HTML][HTML] SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition

…, B Traenkle, PD Kaiser, U Rothbauer, M Becker… - Nature …, 2021 - nature.com
T cell immunity is central for the control of viral infections. To characterize T cell immunity,
but also for the development of vaccines, identification of exact viral T cell epitopes is …

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals

M Becker, A Dulovic, D Junker, N Ruetalo… - Nature …, 2021 - nature.com
SARS-CoV-2 is evolving with mutations in the receptor binding domain (RBD) being of
particular concern. It is important to know how much cross-protection is offered between strains …

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two …

…, C Balaratnasingam, S Banerjee, C Baumal, M Becker… - The Lancet, 2022 - thelancet.com
Background Faricimab is a bispecific antibody that acts through dual inhibition of both
angiopoietin-2 and vascular endothelial growth factor A. We report primary results of two phase 3 …

Bacterial–fungal interactions: ecology, mechanisms and challenges

…, J Uehling, M Paoletti, M Becker… - FEMS microbiology …, 2018 - academic.oup.com
Fungi and bacteria are found living together in a wide variety of environments. Their interactions
are significant drivers of many ecosystem functions and are important for the health of …

[PDF][PDF] Early IFN-α signatures and persistent dysfunction are distinguishing features of NK cells in severe COVID-19

…, R Bals, A Bartholomäus, A Becker, M Becker… - Immunity, 2021 - cell.com
Longitudinal analyses of the innate immune system, including the earliest time points, are
essential to understand the immunopathogenesis and clinical course of coronavirus disease (…

Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients

…, L Lenkeit, N Bruse, J Gerretsen, J Gierlich, M Becker… - Genome medicine, 2021 - Springer
Background The SARS-CoV-2 pandemic is currently leading to increasing numbers of
COVID-19 patients all over the world. Clinical presentations range from asymptomatic, mild …

Optical coherence tomography angiography of the foveal avascular zone in diabetic retinopathy

…, M Pfau, J Wons, MA Wirth, MD Becker… - Graefe's Archive for …, 2016 - Springer
Purpose To analyze foveal avascular zone (FAZ) dimensions and symmetry in patients with
diabetic retinopathy (DR) compared to healthy controls using optical coherence tomography …

[HTML][HTML] Dynamic behavior of transcription factors on a natural promoter in living cells

M Becker, C Baumann, S John, DA Walker… - EMBO …, 2002 - embopress.org
Results We utilized for these experiments a cell line (3134) that contains a tandem array of
the mouse mammary tumor virus (MMTV) promoter, in this report referred to as the MMTV …